{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T22:00:03Z","timestamp":1771711203091,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.vaccine.2008.10.035","type":"journal-article","created":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T08:44:43Z","timestamp":1225529083000},"page":"45-50","source":"Crossref","is-referenced-by-count":44,"title":["The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep"],"prefix":"10.1016","volume":"27","author":[{"given":"O.","family":"Ha\u00e7ar\u0131z","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sayers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"O\u2019Donovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mulcahy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2008.10.035_bib1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4269\/ajtmh.1998.58.417","article-title":"Immunodiagnosis of Fasciola hepatica infection (fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase","volume":"58","author":"O\u2019Neill","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.10.035_bib2","series-title":"Fasciolosis","first-page":"411","article-title":"Human fasciolosis","author":"Mas-Coma","year":"1999"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2008.10.035_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-4017(01)00430-7","article-title":"Parasite vaccines\u2014a reality?","volume":"98","author":"Dalton","year":"2001","journal-title":"Vet Parasitol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.10.035_bib4","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1128\/IAI.64.12.5066-5074.1996","article-title":"Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin","volume":"64","author":"Dalton","year":"1996","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.035_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/rvsc.1998.0270","article-title":"Immune responses of cattle to experimental anti-Fasciola hepatica vaccines","volume":"67","author":"Mulcahy","year":"1999","journal-title":"Res Vet Sci"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2008.10.035_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0304-4017(96)01131-4","article-title":"Fasciola hepatica: vaccination of rabbits with native and recombinant antigens related to fatty acid binding proteins","volume":"69","author":"Muro","year":"1997","journal-title":"Vet Parasitol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.10.035_bib7","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.4049\/jimmunol.145.11.3905","article-title":"Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep","volume":"145","author":"Sexton","year":"1990","journal-title":"J Immunol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2008.10.035_bib8","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0264-410X(96)00147-8","article-title":"Protection of cattle against Fasciola hepatica infection by vaccination with glutathione S-transferase","volume":"14","author":"Morrison","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.10.035_bib9","series-title":"Fasciolosis","first-page":"377","article-title":"Development of vaccines against Fasciola hepatica","author":"Spithill","year":"1999"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.035_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0022-1759(89)90156-7","article-title":"Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies","volume":"121","author":"Kenney","year":"1989","journal-title":"J Immunol Methods"},{"issue":"20","key":"10.1016\/j.vaccine.2008.10.035_bib11","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S1359-6446(03)02864-2","article-title":"Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity","volume":"8","author":"Marciani","year":"2003","journal-title":"Drug Discov Today"},{"issue":"22","key":"10.1016\/j.vaccine.2008.10.035_bib12","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0264-410X(99)00572-1","article-title":"Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration","volume":"18","author":"Baldridge","year":"2000","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2008.10.035_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrmicro1681","article-title":"The perfect mix: recent progress in adjuvant research","volume":"5","author":"Guy","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.035_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF01240612","article-title":"Saponin adjuvants. 3. Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in food-and-mouth disease vaccines","volume":"44","author":"Dalsgaard","year":"1974","journal-title":"Arch Gesamte Virusforsch"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.10.035_bib15","first-page":"1","article-title":"Saponins as vaccine adjuvants","volume":"13","author":"Kensil","year":"1996","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"8","key":"10.1016\/j.vaccine.2008.10.035_bib16","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.4049\/jimmunol.148.8.2357","article-title":"Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses","volume":"148","author":"Newman","year":"1992","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.10.035_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1365-3083.1999.00603.x","article-title":"Quillaja saponin formulations that stimulate proinflammatory cytokines elicit a potent acquired cell-mediated immunity","volume":"50","author":"Behboudi","year":"1999","journal-title":"Scand J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.035_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4049\/jimmunol.146.2.431","article-title":"Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex","volume":"146","author":"Kensil","year":"1991","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.10.035_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1365-3024.1996.d01-20.x","article-title":"Host-protective fragments and antibody binding epitopes of the Taenia ovis 45W recombinant antigen","volume":"18","author":"Lightowlers","year":"1996","journal-title":"Parasite Immunol"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2008.10.035_bib20","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1017\/S003118200600179X","article-title":"Cestode vaccines: origins, current status and future prospects","volume":"133","author":"Lightowlers","year":"2006","journal-title":"Parasitology"},{"issue":"7","key":"10.1016\/j.vaccine.2008.10.035_bib21","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ajcp\/21.7.645","article-title":"The effect of paraffin oil and mycobacteria on antibody formation and sensitization; a review","volume":"21","author":"Freund","year":"1951","journal-title":"Am J Clin Pathol"},{"issue":"19","key":"10.1016\/j.vaccine.2008.10.035_bib22","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1016\/j.vaccine.2007.01.111","article-title":"Vaccine adjuvants revisited","volume":"25","author":"Aguilar","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.10.035_bib23","first-page":"400","article-title":"A retrospective review of lesions associated with the use of Freund's adjuvant","volume":"39","author":"Broderson","year":"1989","journal-title":"Lab Anim Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.035_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ilar.37.3.119","article-title":"Review of selected adjuvants used in antibody production","volume":"37","author":"Jennings","year":"1995","journal-title":"ILAR J"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.035_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ilar.46.3.280","article-title":"Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants","volume":"46","author":"Stills","year":"2005","journal-title":"ILAR J"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.10.035_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-4017(95)00858-6","article-title":"Immune responses of chronically infected adult cattle to Fasciola hepatica","volume":"62","author":"Clery","year":"1996","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2008.10.035_bib27","series-title":"Veterinary parasitology","author":"Urquhart","year":"1996"},{"issue":"Pt 4","key":"10.1016\/j.vaccine.2008.10.035_bib28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1017\/S0031182096008633","article-title":"Production of a monoclonal antibody specific for ovine immunoglobulin E and its application to monitor serum IgE responses to Haemonchus contortus infection","volume":"114","author":"Kooyman","year":"1997","journal-title":"Parasitology"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2008.10.035_bib29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0264-410X(97)00289-2","article-title":"Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica","volume":"16","author":"Mulcahy","year":"1998","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.10.035_bib30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0192-0561(87)90038-5","article-title":"An in vitro study of immunomodulatory effects of some saponins","volume":"9","author":"Chavali","year":"1987","journal-title":"Int J Immunopharmacol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.035_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1586\/14760584.7.1.7","article-title":"Freeing vaccine adjuvants from dangerous immunological dogma","volume":"7","author":"Petrovsky","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.035_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/smim.2000.0236","article-title":"Danger: the view from the bottom of the cliff","volume":"12","author":"Anderson","year":"2000","journal-title":"Semin Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.10.035_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1365-3083.1998.00327.x","article-title":"Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term","volume":"47","author":"Fernando","year":"1998","journal-title":"Scand J Immunol"},{"issue":"17","key":"10.1016\/j.vaccine.2008.10.035_bib34","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0264-410X(99)00526-5","article-title":"CpG DNA induces stronger immune responses with less toxicity than other adjuvants","volume":"18","author":"Weeratna","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.035_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-3024.2000.00290.x","article-title":"Fasciola hepatica infection downregulates Th1 responses in mice","volume":"22","author":"O\u2019Neill","year":"2000","journal-title":"Parasite Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.035_bib36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1128\/IAI.73.1.166-173.2005","article-title":"Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages","volume":"73","author":"Donnelly","year":"2005","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.10.035_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.vetimm.2007.07.003","article-title":"Alternative activation of ruminant macrophages by Fasciola hepatica","volume":"120","author":"Flynn","year":"2007","journal-title":"Vet Immunol Immunopathol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08014229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08014229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:14:18Z","timestamp":1684617258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08014229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0264410X08014229"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.10.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}